Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV

OBJECTIVES: To investigate immunogenicity of SARS-CoV-2 vaccine third booster (3BD; fifth dose) with bivalent vaccine original/BA4/5 vaccine in people living with HIV (PLWH). STUDY DESIGN: This is an observational cohort study to evaluate the outcomes of SARS-CoV-2 vaccination (HIV-VAC study). We an...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergori, Alessandra, Matusali, Giulia, Lepri, Alessandro Cozzi, Cimini, Eleonora, Fusto, Marisa, Colavita, Francesca, Gagliardini, Roberta, Notari, Stefania, Mazzotta, Valentina, Mariotti, Davide, Cicalini, Stefania, Girardi, Enrico, Vaia, Francesco, Maggi, Fabrizio, Antinori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277256/
https://www.ncbi.nlm.nih.gov/pubmed/37343783
http://dx.doi.org/10.1016/j.ijid.2023.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277256/
https://www.ncbi.nlm.nih.gov/pubmed/37343783
http://dx.doi.org/10.1016/j.ijid.2023.06.010

Ejemplares similares